SEARCH:   Advanced

Blood, 15 July 2004, Vol. 104, No. 2, pp. 487-494. Prepublished online as a Blood First Edition Paper on April 1, 2004; DOI 10.1182/blood-2003-12-4341. This Article Full Text Full Text (PDF) All Versions of this Article: 2003-12-4341v1 104/2/487    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lichterfeld, M. Articles by Altfeld, M. Search for Related Content PubMed PubMed Citation Articles by Lichterfeld, M. Articles by Altfeld, M. Related Collections Immunobiology Apoptosis Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  IMMUNOBIOLOGY HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon- and tumor necrosis factor– Mathias Lichterfeld, Xu G. Yu, Michael T. Waring, Stanley K. Mui, Mary N. Johnston, Daniel Cohen, Marylyn M. Addo, John Zaunders, Galit Alter, Eunice Pae, Daryld Strick, Todd M. Allen, Eric S. Rosenberg, Bruce D. Walker, and Marcus Altfeld From the Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, and the Fenway Community Health Care Center, Boston, MA; the Centre for Immunology, St Vincent's Hospital, Sydney, Australia; and the Howard Hughes Medical Institute, Chevy Chase, MD. CD8+ T cells play a crucial role in the control of viral infections by direct elimination of infected cells and secretion of a number of soluble factors. Recent data suggest that HIV-1-specific CD8+ T cell subsets may differ in their ability to exert these effector functions. Here, we directly compared the cytokine secretion patterns and cytotoxic capacity of HIV-1-specific CD8+ T cells, using a flow-cytometric cytotoxicity assay based on caspase-3 activation in dying target cells. These experiments revealed considerable intraindividual and interindividual differences among epitope-specific T-cell effector functions: while the frequency of HIV-1-specific CD8+ T cells secreting interferon- but no tumor necrosis factor- (TNF-) following antigenic stimulation was only weakly correlated to their cytotoxic activity (R = 0.05, P = .57), a subset of CD8+ T cells secreting both inter-feron- and TNF- was substantially more strongly associated with cytotoxicity (R = 0.67, P < .001). This subset of CD8+ T cells also exhibited stronger intracellular perforin expression and more pronounced direct ex vivo HIV-1-specific cytoxicity than CD8+ T cells secreting solely interferon- following sorting of these subpopulations according to their cytokine profile. These results suggest that HIV-1-specific cytotoxicity of CD8+ T cells is preferentially mediated by a subset of CD8+ T cells secreting both interferon- and TNF-. (Blood. 2004;104:487-494) CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: W. Zhou, J. Longmate, S. F. Lacey, J. M. Palmer, G. Gallez-Hawkins, L. Thao, R. Spielberger, R. Nakamura, S. J. Forman, J. A. Zaia, et al. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients Blood, June 18, 2009; 113(25): 6465 - 6476. [Abstract] [Full Text] [PDF] C. Lecuroux, I. Girault, A. Urrutia, J.-M. Doisne, C. Deveau, C. Goujard, L. Meyer, M. Sinet, and A. Venet Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection Blood, April 2, 2009; 113(14): 3209 - 3217. [Abstract] [Full Text] [PDF] D. G. Brooks, S.-J. Ha, H. Elsaesser, A. H. Sharpe, G. J. Freeman, and M. B. A. Oldstone IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection PNAS, December 23, 2008; 105(51): 20428 - 20433. [Abstract] [Full Text] [PDF] A. L. Erickson, C. B. Willberg, V. McMahan, A. Liu, S. P. Buchbinder, L. A. Grohskopf, R. M. Grant, and D. F. Nixon Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses Which Can Be Defined to the Epitope Level Clin. Vaccine Immunol., November 1, 2008; 15(11): 1745 - 1748. [Abstract] [Full Text] [PDF] M. Lichterfeld, D. Mou, T. D. H. Cung, K. L. Williams, M. T. Waring, J. Huang, F. Pereyra, A. Trocha, G. J. Freeman, E. S. Rosenberg, et al. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors Blood, November 1, 2008; 112(9): 3679 - 3687. [Abstract] [Full Text] [PDF] G. Alter, S. Rihn, H. Streeck, N. Teigen, A. Piechocka-Trocha, K. Moss, K. Cohen, A. Meier, F. Pereyra, B. Walker, et al. Ligand-Independent Exhaustion of Killer Immunoglobulin-Like Receptor-Positive CD8+ T Cells in Human Immunodeficiency Virus Type 1 Infection J. Virol., October 1, 2008; 82(19): 9668 - 9677. [Abstract] [Full Text] [PDF] J. R. Bailey, K. O'Connell, H.-C. Yang, Y. Han, J. Xu, B. Jilek, T. M. Williams, S. C. Ray, R. F. Siliciano, and J. N. Blankson Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol., August 1, 2008; 82(15): 7395 - 7410. [Abstract] [Full Text] [PDF] D. G. Brooks, A. M. Lee, H. Elsaesser, D. B. McGavern, and M. B.A. Oldstone IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection J. Exp. Med., March 17, 2008; 205(3): 533 - 541. [Abstract] [Full Text] [PDF] J. W. Critchfield, D. Lemongello, D. H. Walker, J. C. Garcia, D. M. Asmuth, R. B. Pollard, and B. L. Shacklett Multifunctional Human Immunodeficiency Virus (HIV) Gag-Specific CD8+ T-Cell Responses in Rectal Mucosa and Peripheral Blood Mononuclear Cells during Chronic HIV Type 1 Infection J. Virol., June 1, 2007; 81(11): 5460 - 5471. [Abstract] [Full Text] [PDF] F. Bihl, M. Narayan, J. V. Chisholm III, L. M. Henry, T. J. Suscovich, E. E. Brown, T. M. Welzel, D. E. Kaufmann, T. M. Zaman, S. Dollard, et al. Lytic and Latent Antigens of the Human Gammaherpesviruses Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Induce T-Cell Responses with Similar Functional Properties and Memory Phenotypes J. Virol., May 1, 2007; 81(9): 4904 - 4908. [Abstract] [Full Text] [PDF] M. Lichterfeld, K. L. Williams, S. K. Mui, S. S. Shah, B. R. Mothe, A. Sette, A. Kim, M. N. Johnston, N. Burgett, N. Frahm, et al. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily Int. Immunol., July 1, 2006; 18(7): 1179 - 1188. [Abstract] [Full Text] [PDF] Z. Wang, B. Metcalf, R. M. Ribeiro, H. McClure, and A. Kaur Th-1-Type Cytotoxic CD8+ T-Lymphocyte Responses to Simian Immunodeficiency Virus (SIV) Are a Consistent Feature of Natural SIV Infection in Sooty Mangabeys J. Virol., March 15, 2006; 80(6): 2771 - 2783. [Abstract] [Full Text] [PDF] H. S. Bashyam, S. Green, and A. L. Rothman Dengue Virus-Reactive CD8+ T Cells Display Quantitative and Qualitative Differences in Their Response to Variant Epitopes of Heterologous Viral Serotypes. J. Immunol., March 1, 2006; 176(5): 2817 - 2824. [Abstract] [Full Text] [PDF] J. E. Snyder-Cappione, A. A. Divekar, G. M. Maupin, X. Jin, L. M. Demeter, and T. R. Mosmann HIV-Specific Cytotoxic Cell Frequencies Measured Directly Ex Vivo by the Lysispot Assay Can Be Higher or Lower Than the Frequencies of IFN-{gamma}-Secreting Cells: Anti-HIV Cytotoxicity Is Not Generally Impaired Relative to Other Chronic Virus Responses J. Immunol., February 15, 2006; 176(4): 2662 - 2668. [Abstract] [Full Text] [PDF] S. A. Islam, S. Y. Thomas, C. Hess, B. D. Medoff, T. K. Means, C. Brander, C. M. Lilly, A. M. Tager, and A. D. Luster The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans Blood, January 15, 2006; 107(2): 444 - 453. [Abstract] [Full Text] [PDF] Y. Peretz, G. Alter, M.-P. Boisvert, G. Hatzakis, C. M. Tsoukas, and N. F. Bernard Human Immunodeficiency Virus (HIV)-Specific Gamma Interferon Secretion Directed against All Expressed HIV Genes: Relationship to Rate of CD4 Decline J. Virol., April 15, 2005; 79(8): 4908 - 4917. [Abstract] [Full Text] [PDF] S. I. Staprans, A. P. Barry, G. Silvestri, J. T. Safrit, N. Kozyr, B. Sumpter, H. Nguyen, H. McClure, D. Montefiori, J. I. Cohen, et al. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein PNAS, August 31, 2004; 101(35): 13026 - 13031. [Abstract] [Full Text] [PDF]

	Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020